October 13, 2009 – Siemens Healthcare reported today at the annual meeting of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain, that leading hospitals in England, France, Germany and Monaco have shown strong interest and adoption of the Biograph mCT, the worlds first molecular CT, to fuel advanced diagnostic capabilities and to drive greater workflow efficiencies.

October 13, 2009 - Sustained economic growth since 2003 in Brazil, Russia, India, and China (BRIC) has enabled massive increases in healthcare expenditures with an astounding $500 billion spent in 2009 alone, reports Millennium Research Group (MRG), a medical technology market research company.

October 13, 2009 - AMICAS, Inc. is showing its newly launched AMICAS RIS Version 5.5 at RBMA's 2009 Fall Educational Conference in Chandler, AZ, from October 11 to 13, booth 203.

October 12, 2009 – The Society of Cardiovascular Computed Tomography (SCCT) announced four new Category 1 CPT codes for cardiac computed tomography will become effective Jan. 1, 2010.

October 12, 2009 - The FDA notified healthcare professionals that it has become aware of radiation overexposures during perfusion CT imaging performed to aid in the diagnosis of stroke at a particular facility, the patients receiving radiation doses that were approximately eight times the expected level.

October 12, 2009 - Dilon Diagnostics, a molecular breast imaging (MBI), also known as breast-specific gamma imaging (BSGI), device manufacturer, and Philips Healthcare have entered into a distribution agreement, in which Philips will sell and support the Dilon 6800 gamma camera in key European and Middle Eastern markets.

October 9, 2009 - The U.S. Department of Health and Human Services Office of Inspector General (OIG) will open new studies regarding Medicare Part B imaging payments and appropriateness of many emergency department scans according to the recently released OIG Fiscal Year 2010 Work Plan, reported the American College of Radiology.

October 8, 2009 — Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique with comparable sensitivity to breast magnetic resonance imaging (MRI) for detecting breast carcinoma when used in pre-surgical planning for patients with known cancer diagnoses and is substantially less expensive than MRI, according to findings presented today at the American Society of Clinical Oncolog